Joseph Chang

Joseph Chang

Auto-generated profile, based on publicly available information

Joseph Chang

Department of Otolaryngology‐ Head and Neck Surgery University of Washington Seattle Washington USA

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
DWDaniel Winchester
Daniel Winchester
JLJulia Lehman
Julia Lehman
TTTiffany Tello
Tiffany Tello
NCNicolette Chimato
Nicolette Chimato
THThomas Hocker
Thomas Hocker
SASarah T. Arron
Sarah T. Arron

5 March 2018 in Neurosurgery
Verified
Journal Article
Closed access
PDF file
JBJonathan D Breshears
Jonathan D Breshears
JCJoseph Chang
Joseph Chang
AMAnnette M Molinaro
Annette M Molinaro
PSPenny K Sneed
Penny K Sneed
MMMichael W McDermott
Michael W McDermott
PTPhilip V Theodosopoulos
Philip V Theodosopoulos
BACKGROUND: The optimal observation interval after the radiosurgical treatment of a sporadic vestibular schwannoma, prior to salvage intervention, is unknown. OBJECTIVE: To determine an optimal postradiosurgical treatment interval for differentiating between pseudoprogression and true tumor growth by analyzing serial volumetric data. METHODS: This single-institution retrospective study included all sporadic vestibular schwannomas treated with Gamma Knife radiosurgery (Eketa AB, Stockholm, Sweden; 12–13 Gy) from 2002 to 2014. Volumetric analysis was performed on all available pre- and posttreatment magnetic resonance imaging scans. Tumors were classified as “stable/decreasing,” “transient enlargement”, or “persistent growth” after treatment, based on incrementally increasing follow-up durations. RESULTS: A total of 118 patients included in the study had a median treatment tumor volume of 0.74 cm3 (interquartile range [IQR] = 0.34–1.77 cm3) and a median follow-up of 4.1 yr (IQR = 2.6–6.0 yr). Transient tumor enlargement was observed in 44% of patients, beginning at a median of 1 yr (IQR = 0.6–1.4 yr) posttreatment, with 90% reaching peak volume within 3.5 yr, posttreatment. Volumetric enlargement resolved at a median of 2.4 yr (IQR 1.9–3.6 yr), with 90% of cases resolved at 6.9 yr. Increasing follow-up revealed that many of the tumors initially enlarging 1 to 3 yr after stereotactic radiosurgery ultimately begin to shrink on longer follow-up (45% by 4 yr, 77% by 6 yr). CONCLUSION: Tumor enlargement within ∼3.5 yr of treatment should not be used as a sole criterion for salvage treatment. Patient symptoms and tumor size must be considered, and giving tumors a chance to regress before opting for salvage treatment may be worthwhile.

24 June 2008 in Nanotechnology
Verified
Journal Article
Closed access
LBLissett Bickford
Lissett Bickford
JSJiantang Sun
Jiantang Sun
KFKun Fu
Kun Fu
NLNastassja Lewinski
Nastassja Lewinski
VNVengadesan Nammalvar
Vengadesan Nammalvar
RDRebekah Drezek
Rebekah Drezek
We demonstrate the capability of using immunotargeted gold nanoshells as contrast agents for in vitro two-photon microscopy. The two-photon luminescence properties of different-sized gold nanoshells are first validated using near-infrared excitation at 780 nm. The utility of two-photon microscopy as a tool for imaging live HER2-overexpressing breast cancer cells labeled with anti-HER2-conjugated nanoshells is then explored and imaging results are compared to normal breast cells. Five different imaging channels are simultaneously examined within the emission wavelength range of 451-644 nm. Our results indicate that under near-infrared excitation, superior contrast of SK-BR-3 cancer cells labeled with immunotargeted nanoshells occurs at an emission wavelength ranging from 590 to 644 nm. Luminescence from labeled normal breast cells and autofluorescence from unlabeled cancer and normal cells remain imperceptible under the same conditions.

26 August 2020 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
SBSarah K. Brown
Sarah K. Brown
JCJoseph Chang
Joseph Chang
SHShirley Hu
Shirley Hu
GSGanesh Sivakumar
Ganesh Sivakumar
MSMedha Sataluri
Medha Sataluri
MCMark S. Courey
Mark S. Courey


29 June 2020 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
JCJoseph Chang
Joseph Chang
SBSarah K. Brown
Sarah K. Brown
SHShirley Hu
Shirley Hu
GSGanesh Sivakumar
Ganesh Sivakumar
MSMedha Sataluri
Medha Sataluri
MCMark S. Courey
Mark S. Courey